Retinopathy of Prematurity: Current Concepts in Molecular Pathogenesis

REFERENCES

• Terry T L. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am. J. Ophthalmol 1942; 25: 203–204
   Google Scholar
• Gilbert C, Foster A. Childhood blindness in the context of VISION 2020–the right to sight. Bull. World Health Organ 2001; 79: 227–232
   PubMed Web of Science ®Google Scholar
• Gilbert C, Muhit M. Twenty years of childhood blindness: What have we learnt?. Community Eye Health 2008; 21: 46–47
   PubMedGoogle Scholar
• Gilbert C, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implications for screening programs. Pediatrics 2005; 115: e518–e525
   PubMed Web of Science ®Google Scholar
• Cryotherapy for retinopathy of prematurity cooperative group. Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results. Archives of Ophthalmology 1988; 106: 471–479
   PubMedGoogle Scholar
• Shalev B, Farr A K, Repka M X. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: Seven-year outcome. Am. J. Ophthalmol 2001; 132: 76–80
   Google Scholar
• Tasman W. Ten-year follow-up from the CRYO-ROP study. Arch. Ophthalmol 2001; 119: 1200–1201
   Google Scholar
• Michaelson I C. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans. Ophthalmol. Soc. U. K 1948; 68: 137–180
   Google Scholar
• Ashton N, Ward B, Serpell G. Effect of oxygen of developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br. J. Ophthalmol 1954; 38: 397–432
   PubMed Web of Science ®Google Scholar
• Roth A M. Retinal vascular development in premature infants. Am. J. Ophthalmol 1977; 84: 636–640
   PubMed Web of Science ®Google Scholar
• Hughes S, Yang H, Chan-Ling T. Vascularization of the human fetal retina: Roles of vasculogenesis and angiogenesis. Invest Ophthalmol. Vis. Sci 2000; 41: 1217–1228
   PubMed Web of Science ®Google Scholar
• Chan-Ling T, et al. Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Ophthalmol. Vis. Sci 2004; 45: 2020–2032
   PubMed Web of Science ®Google Scholar
• Lutty G A, et al. Proceedings of the Third International Symposium on Retinopathy of Prematurity: An update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol. Vis 2006; 12: 532–580
   PubMed Web of Science ®Google Scholar
• Patz A. Clinical and experimental studies on retinal neovascularization. Am. J. Ophthalmol 1982; 94: 715–743
   PubMed Web of Science ®Google Scholar
• Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division. Evidence that ‘physiological hypoxia’ is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol. Vis. Sci 1995; 36: 1201–1214
   PubMed Web of Science ®Google Scholar
• Smith L E. Through the eyes of a child: Understanding retinopathy through ROP the Friedenwald lecture. Invest Ophthalmol. Vis. Sci 2008; 49: 5177–5182
   PubMed Web of Science ®Google Scholar
• Madan A, Penn J S. Animal models of oxygen-induced retinopathy. Front Biosci 2003; 8: d1030–d1043
   PubMedGoogle Scholar
• Smith L E, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol. Vis. Sci 1994; 35: 101–111
   PubMed Web of Science ®Google Scholar
• Leung D W, Cachianes G, Kuang W J, Goeddel D V, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843–845
   PubMed Web of Science ®Google Scholar
• Penn J S, et al. Vascular endothelial growth factor in eye disease. Prog. Retin. Eye Res 2008; 27: 331–371
   PubMed Web of Science ®Google Scholar
• Stone J, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci 1995; 15: 4738–4747
   PubMed Web of Science ®Google Scholar
• Pierce E A, Foley E D, Smith L E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol 1996; 114: 1219–1228
   PubMedGoogle Scholar
• Shih S C, Ju M, Liu N, Smith L E. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J. Clin. Invest 2003; 112: 50–57
   PubMed Web of Science ®Google Scholar
• Pierce E A, Avery R L, Foley E D, Aiello L P, Smith L E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. U. S. A 1995; 92: 905–909
   PubMed Web of Science ®Google Scholar
• Robinson G S, et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc. Natl. Acad. Sci. U. S. A 1996; 93: 4851–4856
   PubMed Web of Science ®Google Scholar
• Jiang J, et al. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. J. Cell Physiol 2009; 218: 66–74
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Roccaro A M, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest 2003; 33: 891–896
   PubMed Web of Science ®Google Scholar
• Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck K H. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc. Res 2002; 64: 326–333
   PubMed Web of Science ®Google Scholar
• Morita M, et al. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 2003; 22: 1134–1146
   PubMed Web of Science ®Google Scholar
• Chen J, Connor K M, Aderman C M, Smith L E. Erythropoietin deficiency decreases vascular stability in mice. J. Clin. Invest 2008; 118: 526–533
   PubMed Web of Science ®Google Scholar
• Chen J, et al. Erythropoietin siRNA suppresses retinal neovascularization in a mouse model of proliferative retinopathy. Invest Ophthalmol. Vis. Sci 2008
   Google Scholar
• Suk K K, et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: A multiple regression model. J. AAPOS 2008; 12: 233–238
   Web of Science ®Google Scholar
• Chen J, Smith L E. A double-edged sword: Erythropoietin eyed in retinopathy of prematurity. J. AAPOS 2008; 12: 221–222
   PubMed Web of Science ®Google Scholar
• Langford K, Nicolaides K, Miell J P. Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Human Reproduction 1998; 13: 1389–1393
   PubMedGoogle Scholar
• Hellstrom A, et al. IGF-I is critical for normal vascularization of the human retina. J. Clin. Endocrinol. Metab 2002; 87: 3413–3416
   PubMed Web of Science ®Google Scholar
• Hellstrom A, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. U. S. A 2001; 98: 5804–5808
   PubMed Web of Science ®Google Scholar
• Smith L E, et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997; 276: 1706–1709
   PubMed Web of Science ®Google Scholar
• Smith L E, et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med 1999; 5: 1390–1395
   PubMed Web of Science ®Google Scholar
• Mukherjee P K, Chawla A, Loayza M S, Bazan N G. Docosanoids are multifunctional regulators of neural cell integrity and fate: Significance in aging and disease. Prostaglandins Leukot. Essent. Fatty Acids 2007; 77: 233–238
   PubMed Web of Science ®Google Scholar
• Lukiw W J, Bazan N G. Docosahexaenoic acid and the aging brain. J. Nutr 2008; 138: 2510–2514
   PubMed Web of Science ®Google Scholar
• Connor K M, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med 2007; 13: 868–873
   PubMed Web of Science ®Google Scholar